Primrose Bio emerges as biotech powerhouse, secures $15m from Ligand Pharmaceuticals

Primrose Bio emerges as biotech powerhouse, secures $15m from Ligand Pharmaceuticals

Primrose Bio, Inc. has been founded as a merger between Primordial Genetics, Inc. and Pelican Technology Holdings, Inc in a transformative move that sets the stage for groundbreaking advancements in biotechnology. The newly-formed private biotechnology company has also received a substantial $15 million funding contribution from Ligand Pharmaceuticals. Primrose Bio aims to revolutionize the discovery […]

Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex

Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex

US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a development and licensing biotechnology company engaged in the development of protein therapeutics, which are used in various commercial and development-stage biopharma drug candidates. As per the terms of the deal, Ligand Pharmaceuticals is offering to acquire the […]